Do you need a doctor consultation before peptide therapy?

For prescription peptide or peptide-adjacent therapy, yes. A licensed clinician should review whether treatment is appropriate, what product fits the goal, what risks or interactions apply, and whether a prescription can be issued safely. No-prescription peptide sales are a red flag for human treatment.

Sometimes. Telehealth may be appropriate when the clinician has enough history, medication, allergy, pregnancy, lab, and symptom information and can legally treat the patient. Some situations require labs, records, primary-care coordination, specialist input, urgent care, or an in-person exam first.

Programs vary, but patients should understand what any fee covers and whether payment happens before eligibility is known. At Peptide12, payment, financing, or an intake submission should not be framed as guaranteed approval, a guaranteed refill, or a guarantee of a specific product. Be cautious if a site sells prescription-strength peptides before medical screening, hides the clinician or pharmacy, or guarantees approval.

No. A consultation is a clinical review that may approve, delay, decline, or redirect treatment. Buying peptides online from a marketplace, research-use seller, or no-prescription vendor does not replace licensed medical evaluation, prescription decisions, pharmacy sourcing, or follow-up.

Yes. Patients should know whether the option is an FDA-approved branded drug, an individualized compounded prescription, an off-label use, or an evidence-limited wellness product. Compounded finished medications are not FDA-approved in the same way as approved branded drugs.

A decline or delay can be a safety decision. Ask what information is missing, whether labs or records would help, whether primary care or specialist evaluation is recommended, and what safer alternatives or timing may make sense. Avoid guaranteed-approval sellers after a decline.